Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[Clinical Features and Prognostic Factors of 18 Children with Anaplastic Large Cell Lymphoma].

Chen C, Zheng YZ, Hua XL, Zheng H, Chen ZS, LE SH, Zheng L, Li M, Cai CX, Yang JH, Chen YQ, Chen YY, Gao QL, Li J, Hu JD.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Jun;27(3):809-915. doi: 10.19746/j.cnki.issn.1009-2137.2019.03.027. Chinese.

PMID:
31204936
2.

Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.

Agrawal K, Shet T, Sridhar E, Dhende S, Sengar M, Arora B, Laskar S, Gujral S, Menon H, Banavali S.

Indian J Pathol Microbiol. 2017 Oct-Dec;60(4):533-540. doi: 10.4103/IJPM.IJPM_778_15.

3.

[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].

Guo J, Zhu YP, Gao J, Li Q, Jia CS, Zhou CY, Guo X.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):72-9. doi: 10.7534/j.issn.1009-2137.2016.01.014. Chinese.

PMID:
26913397
4.

ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.

Huang L, Zhang F, Zeng J, Guo H, Liu S, Wei X, Chen F, Jiang X, Liang Z, Liu Y, Li W.

Ann Hematol. 2018 Jan;97(1):149-159. doi: 10.1007/s00277-017-3166-8. Epub 2017 Nov 17.

PMID:
29150811
5.

Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.

Wang YF, Yang YL, Gao ZF, Zhou CJ, Gregg X, Shi YF, Wang J, Yang XF, Ke XY.

J Hematol Oncol. 2012 Jul 7;5:38. doi: 10.1186/1756-8722-5-38.

6.

Anaplastic large cell lymphoma: a single institution experience from India.

Lakshmaiah KC, Guruprasad B, Shah A, Kavitha S, Abraham LJ, Govindbabu K, Aruna Kumari BS, Appaji L.

J Cancer Res Ther. 2013 Oct-Dec;9(4):649-52. doi: 10.4103/0973-1482.126468.

7.

Anaplastic large cell lymphoma, ALK-negative.

Ferreri AJ, Govi S, Pileri SA, Savage KJ.

Crit Rev Oncol Hematol. 2013 Feb;85(2):206-15. doi: 10.1016/j.critrevonc.2012.06.004. Epub 2012 Jul 11. Review.

8.

Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood.

Vecchi V, Burnelli R, Pileri S, Rosito P, Sabattini E, Civino A, Pericoli R, Paolucci G.

Med Pediatr Oncol. 1993;21(6):402-10.

PMID:
8390600
9.

[Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].

Meng JH, Gao YJ, Lu FJ, Zhai XW, Wang HS, Li J.

Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):222-7. doi: 10.3760/cma.j.issn.0253-3766.2012.03.014. Chinese.

PMID:
22780979
10.

[Clinical features and therapeutic effect of 38 children with anaplastic large cell lymphoma].

Yang J, Jin L, Zheng HY, Zhang R, Duan YL, Huang S, Zhou CJ, Zhang YH.

Zhonghua Er Ke Za Zhi. 2012 Mar;50(3):223-6. Chinese.

PMID:
22801210
11.

Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.

Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.

Leukemia. 2000 Sep;14(9):1533-59. Review.

PMID:
10994999
12.

Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.

Deng XW, Zhang XM, Wang WH, Wang SL, Jin J, Fang H, Ren H, Liu YP, He XH, Dong M, Song YW, Li YX.

Ann Hematol. 2016 Aug;95(8):1271-80. doi: 10.1007/s00277-016-2696-9. Epub 2016 May 21.

PMID:
27209536
13.

Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, Morris SW, Connors JM, Vose JM, Viswanatha DS, Coldman A, Weisenburger DD.

Blood. 1999 Jun 1;93(11):3913-21.

14.

Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.

Weisenburger DD, Anderson JR, Diebold J, Gascoyne RD, MacLennan KA, Müller-Hermelink HK, Nathwani BN, Ullrich F, Armitage JO.

Am J Hematol. 2001 Jul;67(3):172-8. Review.

15.

Anaplastic large cell lymphoma--a rare disorder in southern Taiwan.

Lin CN, Hou CC, Hwang WS, Chuang SS.

Leuk Lymphoma. 2003 Oct;44(10):1727-31.

PMID:
14692525
16.

Clinicopathological characteristics of primary Ki-1 anaplastic large cell lymphoma.

Kobayashi T, Nagasawa T, Mitsuhashi S, Hasegawa Y, Kojima H, Ninomiya H, Mori N, Abe T.

Int J Hematol. 1996 Jan;63(1):41-50.

PMID:
8713576
17.

[Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].

Shi Y, Chen G, Zhou XG, Gong LP, Yu R, Zheng YY, Xie JL, Jin Y.

Zhonghua Bing Li Xue Za Zhi. 2010 Apr;39(4):235-9. Chinese.

PMID:
20654121
18.

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.

Eyre TA, Khan D, Hall GW, Collins GP.

Eur J Haematol. 2014 Dec;93(6):455-68. doi: 10.1111/ejh.12360. Epub 2014 May 21. Review.

PMID:
24766435
19.

Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group.

Chen SH, Chen JS, Jou ST, Wu KH, Hung IJ, Sheen JM, Lu MY, Chen BW, Jaing TH, Wang SC, Lin MT, Chang TK, Liu HC, Yang CP.

Leuk Lymphoma. 2019 Aug;60(8):1942-1949. doi: 10.1080/10428194.2018.1562182. Epub 2019 Jan 15.

PMID:
30646784
20.

Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.

Samuelsson BO, Ridell B, Röckert L, Gustafsson G, Márky I.

J Pediatr Hematol Oncol. 1999 Mar-Apr;21(2):103-10.

PMID:
10206455

Supplemental Content

Support Center